News
TCRT
2.870
-1.03%
-0.030
Weekly Report: what happened at TCRT last week (0428-0502)?
Weekly Report · 3d ago
Weekly Report: what happened at TCRT last week (0421-0425)?
Weekly Report · 04/28 12:03
Weekly Report: what happened at TCRT last week (0414-0418)?
Weekly Report · 04/21 12:03
Alaunos Therapeutics Board Opts for Equity Compensation
TipRanks · 04/15 21:30
Weekly Report: what happened at TCRT last week (0407-0411)?
Weekly Report · 04/14 11:49
Weekly Report: what happened at TCRT last week (0331-0404)?
Weekly Report · 04/07 11:49
These 3 Healthcare Stocks Show Serious Muscle Amid Trump Tariff Turmoil: Are Retail Traders Feeling Bullish?
Barchart · 04/07 00:40
11 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 04/03 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 04/02 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 04/01 17:05
Weekly Report: what happened at TCRT last week (0324-0328)?
Weekly Report · 03/31 12:03
Weekly Report: what happened at TCRT last week (0317-0321)?
Weekly Report · 03/24 11:49
Weekly Report: what happened at TCRT last week (0310-0314)?
Weekly Report · 03/17 12:01
Weekly Report: what happened at TCRT last week (0303-0307)?
Weekly Report · 03/10 12:04
Weekly Report: what happened at TCRT last week (0224-0228)?
Weekly Report · 03/03 12:03
Weekly Report: what happened at TCRT last week (0217-0221)?
Weekly Report · 02/24 12:02
Weekly Report: what happened at TCRT last week (0210-0214)?
Weekly Report · 02/17 11:59
Weekly Report: what happened at TCRT last week (0203-0207)?
Weekly Report · 02/10 11:51
Weekly Report: what happened at TCRT last week (0127-0131)?
Weekly Report · 02/03 11:57
Weekly Report: what happened at TCRT last week (0120-0124)?
Weekly Report · 01/27 12:01
More
Webull provides a variety of real-time TCRT stock news. You can receive the latest news about Alaunos Therapeutics, Inc through multiple platforms. This information may help you make smarter investment decisions.
About TCRT
More
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.